Contineum Therapeutics (CTNM) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

CTNM Contineum Therapeutics

Watchlist

17.750
+0.750+4.41%

Trading Oct 7 14:14 ET

456.59MMarket Cap-23111P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

We're Interested To See How Contineum Therapeutics (NASDAQ:CTNM) Uses Its Cash Hoard To Grow
Simply Wall StOct 7 11:36 ET
Contineum Therapeutics, Inc.'s (NASDAQ:CTNM) Largest Shareholders Are Individual Investors With 41% Ownership, Institutions Own 28%
Yahoo FinanceOct 4 07:40 ET
IPO Roundup: FrontView REIT, StandardAero and More
Seeking AlphaSep 30 09:44 ET
Contineum Therapeutics Is Maintained at Outperform by RBC Capital
Dow JonesAug 14 11:36 ET
Contineum Therapeutics Analyst Ratings
BenzingaAug 14 11:24 ET · Ratings
Morgan Stanley Maintains Contineum Therapeutics(CTNM.US) With Buy Rating, Maintains Target Price $25
Moomoo NewsAug 14 09:31 ET · Ratings

Comments

Pinchie McPincher

Apr 19 03:23

$Contineum Therapeutics (CTNM.US)$what am i missing?

Jaguar8

Apr 4 22:56

$Contineum Therapeutics (CTNM.US)$
NEWS
Contineum Therapeutics, Inc. announces pricing of IPO, offering 6,875,000 shares of Class A common stock at $16.00 per share, expecting gross proceeds of $110.0 million. Shares to trade on Nasdaq under symbol 'CTNM'.